Ceftizoxime 1gm/2gm

Ceftizoxime 1gm/2gm

Product Name :

Voriconazole Injection IP 200 Mg

Available Strength :

200 mg

Packing :

Vial / As per your requirement

Pack Insert/ Leaflet :

Available upon request

Therapeutical Use :

Antifungal

Production Capacity :

Available on request

Description:

What is Ceftizoxime Injection 1 g / 2 g?

Ceftizoxime Injection is a cephalosporin-class antibiotic intended for use by healthcare professionals in treating certain bacterial infections caused by susceptible organisms. It works by interfering with bacterial cell-wall synthesis. The supplied product details list 1 g and 2 g strengths, with a 1 g vial with WFI specified in the presentation. Product-specific details should be confirmed before supply or use.

Uses / Indications

Ceftizoxime may be used to treat selected bacterial infections caused by susceptible organisms. The specific approved indications depend on the product information, infection site, bacterial susceptibility and the patient’s clinical condition.

Benefits

  • Provides a cephalosporin-class antibiotic option for susceptible bacterial infections.

  • May be suitable for clinical settings where injectable antibiotic treatment is indicated.

  • Supports antibiotic selection guided by susceptibility results and professional assessment.

Side Effects

Possible side effects vary depending on the patient, dose and treatment circumstances.

Common side effects

  • Diarrhoea

  • Nausea or vomiting

  • Skin rash

  • Injection-site discomfort

Less common or serious side effects

  • Severe allergic reactions, including anaphylaxis

  • Severe or persistent diarrhoea

  • Serious skin reactions

  • Changes in liver function or blood cell counts

Seek urgent medical attention if signs of a severe allergic reaction or another serious adverse effect occur.

How Does It Work?

Ceftizoxime inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins. This disrupts the formation of a stable bacterial cell wall and can lead to bacterial cell death. Its effectiveness depends on the susceptibility of the infecting organism and appropriate clinical use.

Dosage Guidelines

The appropriate dose and treatment duration depend on the type and severity of infection, bacterial susceptibility, patient age, kidney function and the approved product information.

The exact dose, administration route, frequency and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

Preparation and administration must follow the approved instructions for the specific product. Confirm the correct strength and supplied WFI presentation before use.

When Not to Use

  • In patients with a known serious hypersensitivity to ceftizoxime or any product component.

  • In patients with a history of severe reactions to cephalosporins or other beta-lactam antibiotics, unless a qualified healthcare professional has assessed the risks and suitability of treatment.

Drug / Product Interactions

Potential interaction considerations include:

  • Other antibiotics: Concurrent use should be based on the clinical indication and prescribing guidance.

  • Medicines affecting kidney function: Additional monitoring may be required in patients with renal impairment or when using medicines that affect renal function.

  • Anticoagulants: Monitoring may be appropriate depending on the patient’s clinical circumstances and medication regimen.

  • Other prescribed medicines: The complete medication list should be reviewed by a healthcare professional.

Refer to the approved product information for product-specific interaction details.

Safety Advice

  • Use only under the supervision of a qualified healthcare professional.

  • Review the patient’s allergy history before administration.

  • Use antibiotics only for appropriate bacterial infections.

  • Follow approved preparation, administration and infection-control procedures.

  • Monitor for allergic reactions and other clinically significant adverse effects.

General Instructions

  • Verify the product name, strength and vial presentation before use.

  • Follow the approved instructions for preparation and administration.

  • Do not use damaged packaging or a vial that does not meet the required specifications.

  • Confirm storage conditions and instructions for use after preparation from the approved product label.

Special Dietary / Lifestyle Tips

No specific diet is universally required solely because of ceftizoxime treatment. Patients should follow their healthcare professional’s advice, maintain adequate hydration when appropriate and adhere to the prescribed treatment plan.

Comparison with Other Treatments

Ceftizoxime belongs to the cephalosporin class of beta-lactam antibiotics. Other cephalosporins and antibiotic classes differ in their antibacterial activity and approved indications. Treatment selection depends on the suspected or confirmed organism, susceptibility results, infection site, local resistance patterns and patient-specific factors.

Precautions & Warnings

  • Allergy risk: Confirm any previous reactions to cephalosporins, penicillins or other beta-lactam antibiotics.

  • Kidney function: Renal impairment may affect dosing requirements.

  • Antibiotic resistance: Inappropriate use can contribute to antimicrobial resistance.

  • Superinfection: Prolonged or inappropriate treatment may allow non-susceptible organisms to grow.

  • Presentation verification: Confirm whether the 2 g strength is available in the required vial presentation and whether WFI is supplied with each strength.

Can I Use It With Other Medicines?

Generally Compatible With

Other medicines may be used when clinically indicated, subject to review by the treating healthcare professional and the approved product information.

Use With Caution

  • Other antibiotics used as part of combination treatment

  • Medicines that may affect kidney function

  • Anticoagulants or medicines requiring additional clinical monitoring

Avoid

Avoid use in patients with a known serious hypersensitivity to ceftizoxime or any product component. Do not mix the injection with other medicines in the same syringe or infusion container unless compatibility is established by the approved product information.

Storage

Store according to the conditions stated on the approved product label. Follow product-specific instructions for preparation, handling and use after reconstitution. Do not assume a storage temperature or post-preparation shelf life without verified product information.

Frequently Asked Questions

1. What is Ceftizoxime Injection used for?

It is used for selected bacterial infections caused by susceptible organisms, according to the approved product information.

2. What strengths are listed?

The supplied product details list 1 g and 2 g strengths.

3. What is the active ingredient?

The active ingredient is ceftizoxime.

4. Does the product come with WFI?

The supplied description specifies a 1 g vial with WFI. The presentation for each available strength should be confirmed against the approved product specification.

5. Does ceftizoxime treat viral infections?

No. Ceftizoxime is an antibiotic for susceptible bacterial infections and does not treat viral illnesses such as colds or influenza.

6. Does kidney function affect treatment?

Yes. Renal function may affect dosing requirements, so the treating healthcare professional should assess kidney function where appropriate.

7. Who should administer the injection?

A qualified healthcare professional should prepare and administer the product according to the approved instructions.

8. Can Kelar Pharmachem India support sourcing enquiries?

Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries. Product specifications, supporting documentation and destination-market requirements are subject to confirmation.

Scroll to Top